Advanced Therapies for Pediatric Obesity

Registration will close at 12 noon CST on Wednesday 2/23.

Format: Live Webinar

Registered individuals can access the Zoom webinar link under the "Access Course" tab.

This course is planned and hosted by the University of Minnesota Department of Pediatrics. For more information please contact the Center for Pediatric Obesity Medicine, [email protected] or 612-626-2349.  You can also visit the Center for Pediatric Obesity Medicine website. 

Advanced Therapies for Pediatric Obesity is an activity intended for its learners to utilize pharmacotherapy for pediatric obesity in a safe and responsible fashion while identifying biological targets of obesity treatments and the mechanisms of actions and outcomes of currently FDA approved and off-label medications for the treatment of obesity in adults and youth.

Agenda with time zones is available here

1. Discuss the pathophysiology of obesity and the weight-reduced state and how to apply this knowledge to treatment strategies for pediatric obesity.
2. Recognize how weight-related comorbidities contribute to worsening obesity and how to intervene.
3. Recall comprehensive strategies for the management of pediatric obesity using nutrition, physical activity, behavior, medications, and surgery.

Physician: $300.00

Other Healthcare Professional: $300.00

Resident/Fellow/Student: $150.00

Credit Designation Statements

American Medical Association (AMA)

The University of Minnesota, Interprofessional Continuing Education designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals

Other healthcare professionals who participate in this CE activity may submit their statement of participation to their appropriate accrediting organizations or state boards for consideration of credit. The participant is responsible for determining whether this activity meets the requirements for acceptable continuing education.

Cancellation Policy

If you need to cancel your registration, the registration fee, less a $50 administrative fee, will be refunded if we receive a two-week notice prior to the activity. No refunds will be made after that. 

UMN Office of Continuing Professional Development (OCPD) and/or our partner in providing the activity reserves the right to cancel any activity due to unforeseen circumstances. In the event the activity is cancelled, registration fees will be refunded. UMN OCPD and/or our partner in providing the activity is not responsible for any travel-related costs, charges, or expenses, including but not limited to fees assessed by airline, travel, or lodging agencies

Mitigation of Relevant Financial Relationships

University of Minnesota Continuing Professional Development adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education and has policies in place to ensure balance, independence, objectivity and scientific rigor in all of its educational activities. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities; individuals who fail to complete the disclosure in advance of the course are not eligible to be involved in this course. Specific disclosure information will be shared with learners prior to the start of the course. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Aaron Kelly, PhD
University of Minnesota

Co-Director, Faculty

Other: Drug / Placebo Donation -Vivus Pharmaceuticals

Claudia Fox, MD, MPH
University of Minnesota

Course Director, Faculty

Contracted Research-Novo Nordisk and Rhythm Pharmaceuticals

Megan 0 Bensignor, MD
Assistant Professor
University of Minnesota

Faculty

Nothing to disclose

Melanie Cree-Green, MD, PhD
University of Colorado Anschutz Medical Campus

Faculty

Nothing to disclose

Joan C Han, MD
Professor
Icahn School of Medicine at Mount Sinai

Faculty

Grant or research support-Rhythm Pharmaceuticals

Ania Jastreboff, MD, PhD
Associate Professor
Yale University School of Medicine

Faculty

Advisor-Novo Nordisk (Any division)|Advisor-Lilly (Any division)|Advisor-Boehringer Ingelheim Pharmaceuticals, Inc.|Advisor-Rhythm Pharmaceuticals|Grant or research support-Novo Nordisk (Any division)|Grant or research support-Lilly (Any division)|Advisor-WW

Leah M Lessard, PhD
University of Connecticut

Faculty

Nothing to disclose

Jaime Moore, MD, MPH
Assistant Professor
University of Colorado School of Medicine

Faculty

Nothing to disclose

Valerie M. O'Hara, DO
WOW 4 WellnessClinic

Faculty

Nothing to disclose

Mary Savoye, MS, RD, CD-N, CDE
Associate Director, Pediatric Obesity
Yale University

Faculty

Nothing to disclose

Brooke Sweeney, MD
Children's Mercy Kansas City

Faculty

Nothing to disclose

Amy Gross, PhD
Associate Professor
University of Minnesota

Faculty, Planning Committee Member

Grant or research support-Rhythm Pharmaceuticals (Relationship has ended)

Justin R Ryder, PhD
Associate Professor
Lurie Children's Hospital

Faculty, Planning Committee Member

Grant or research support-Boehringer Ingelheim Pharmaceuticals, Inc.